GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Cyclically Adjusted PS Ratio

Inoviq (ASX:IIQ) Cyclically Adjusted PS Ratio : (As of Jun. 08, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Inoviq Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Inoviq Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Inoviq's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq Cyclically Adjusted PS Ratio Chart

Inoviq Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 40.70 83.26 183.01

Inoviq Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 83.26 - 183.01 -

Competitive Comparison of Inoviq's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Inoviq's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inoviq's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inoviq's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Inoviq's Cyclically Adjusted PS Ratio falls into.



Inoviq Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Inoviq's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Jun23 is calculated as:

For example, Inoviq's adjusted Revenue per Share data for the fiscal year that ended in Jun23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun23 (Change)*Current CPI (Jun23)
=0.004/124.1700*124.1700
=0.004

Current CPI (Jun23) = 124.1700.

Inoviq Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 98.352 0.000
201506 0.000 99.838 0.000
201606 0.000 100.859 0.000
201706 0.000 102.809 0.000
201806 0.000 104.945 0.000
201906 0.000 106.617 0.000
202006 0.000 106.246 0.000
202106 0.006 110.332 0.007
202206 0.003 117.112 0.003
202306 0.004 124.170 0.004

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Inoviq  (ASX:IIQ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Inoviq Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Inoviq's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Inoviq (ASX:IIQ) Business Description

Traded in Other Exchanges
N/A
Address
23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168
Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq (ASX:IIQ) Headlines

No Headlines